well, 2 out of 3 ain't bad - I guess "AMBS just
Post# of 30028
Posted On: 01/04/2015 10:29:56 AM
well, 2 out of 3 ain't bad - I guess
"Amarantus plans to launch LymPro for RUO in the 4Q14, primarily targeting pharmaceutical clinical trials. The company does not require CLIA certification to launch LymPro in the RUO market."
http://biotuesdays.com/2014/10/09/amarantus-p...ata-in-ad/
Quote:
"AMBS just needs to get Lympro established in RUO, CLIA approved, and some sort of global expansion."
"Amarantus plans to launch LymPro for RUO in the 4Q14, primarily targeting pharmaceutical clinical trials. The company does not require CLIA certification to launch LymPro in the RUO market."
http://biotuesdays.com/2014/10/09/amarantus-p...ata-in-ad/
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼